Jon P. Stonehouse, President & CEO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 184,000 shares at $15.04 ($2.8M) on 2022-01-11, disclosed to the SEC on 2022-01-13.
Seasonal sale ($2.8M) by President & CEO — this insider has traded BCRX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| BCRX | SELL | 2022-12-19 | $154K | — | Filing → |
| BCRX | SELL | 2022-12-02 | $4.9M | — | Filing → |
| BCRX | SELL | 2020-12-17 | $2.2M | — | Filing → |